Aptose Biosciences Inc. (APS.TO)
Toronto - Toronto Real Time Price. Currency in CAD
Add to watchlist
3.1600-0.1100 (-3.36%)
At close: 3:59PM EST
| Previous Close | 3.2700 |
| Open | 3.2800 |
| Bid | 3.1100 x N/A |
| Ask | 3.1200 x N/A |
| Day's Range | 3.1100 - 3.2800 |
| 52 Week Range | 2.5100 - 9.4000 |
| Volume | 38,607 |
| Avg. Volume | 45,847 |
| Market Cap | 281.061M |
| Beta (5Y Monthly) | 1.31 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.8680 |
| Earnings Date | Nov. 08, 2021 - Nov. 12, 2021 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Zacks
Implied Volatility Surging for Aptose Biosciences (APTO) Stock Options
Investors need to pay close attention to Aptose Biosciences (APTO) stock based on the movements in the options market lately.
- Zacks
Why Investors Should Hold on to Universal Health (UHS) Stock
Universal Health (UHS) can bank on balance sheet strength for future acquisitions to grow its business inorganically.
- GlobeNewswire
Aptose to Present at the Piper Sandler 33rd Annual Healthcare Conference
SAN DIEGO and TORONTO, Nov. 22, 2021 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (Nasdaq: APTO; TSX: APS), a clinical-stage company developing highly differentiated therapeutics that target the underlying mechanisms of cancer, today announced that the Aptose management team will be participating in the Piper Sandler 33rd Annual Healthcare Conference, being held virtually. The Aptose presentation will take the form of a pre-recorded fireside chat, which will be available on the Piper Sandler conf
